SWOT Analysis: Psilocybin-Assisted Alcohol Use Disorder Outpatient Program
A structured outpatient program combining supervised psilocybin sessions with cognitive-behavioral therapy for adults with alcohol use disorder. The program targets patients who have not responded to traditional treatments, utilizing a protocol that has reduced heavy drinking days from 23.6% to 9.7% over 32 weeks.
The SWOT analysis reveals a high-efficacy clinical intervention that outperforms traditional pharmacotherapies for treatment-resistant AUD, but faces significant operational hurdles. While market demand among high-income professionals is strong, the model is heavily constrained by a fragmented legal landscape and the high cost of supervised clinical delivery.
Strengths3
Weaknesses3
Opportunities3
Threats3
This helps balance the strong clinical efficacy (strength) against the significant safety risks and psychiatric contraindications (weakness). · Generated 2026-09-11 by cavi/gemma4-31b-it-awq-4bit-32kAI-generated